Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Acq. announced
Consulting agrmnt

Enliven Therapeutics, Inc. (IMRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/10/2023 SC 13G FMR LLC reports a 10.7% stake in ENLIVEN THERAPEUTICS INC
04/27/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/13/2023 SC 13G Venrock Healthcare Capital Partners III, L.P. reports a 5.4% stake in Enliven Therapeutics, Inc.
03/06/2023 SC 13G CITADEL ADVISORS LLC reports a 5.6% stake in Enliven Therapeutics, Inc.
10/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/14/2022 SC 13G BML Investment Partners, L.P. reports a 6.2% stake in IMARA INC
02/03/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/10/2020 SC 13G FMR LLC reports a 11.6% stake in IMARA INC
03/26/2020 SC 13G PFIZER INC reports a 9.4% stake in IMARA Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy